
Coya Therapeutics Advances ALS Trial Following Health Canada Acceptance
Houston, December 24, 2025 Coya Therapeutics, based in Houston, has achieved a significant regulatory milestone with Health Canada’s acceptance of its Clinical Trial Application for the








